Sign in

ATPC on Nasdaq

Agape ATP Corp

Agape ATP Corp is an American health services company based in Kuala Lumpur, incorporated in Nevada.2 Its shares trade on Nasdaq under the symbol ATPC.2

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Longduoduo Co Ltd, EUDA Health Holdings Ltd or VSEE HEALTH, INC., or pick any stock.

  • TickerATPC on Nasdaq2
  • IndustryServices-Health Services2
  • HeadquartersKuala Lumpur, Malaysia2
  • Incorporated inNV3
  • Business address1705-1708 Level 17, Tower 2, Faber Tower, Jalan Desa Bahagia, Taman Desa, Kuala Lumpur, N8 581003
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formProfit Corporation2
  • LEI875500HDXW0PWGM8ZB922
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered address1645 Village Center Circle, Suite 17, 89134 Las Vegas, United States2
  • Registered withBusiness Center (Secretary of State), E0248912016-92

See how the biggest companies compare on our leaderboards

ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

55.0%Gross margin5
-213.7%Operating margin5
-149.6%Net margin5
15.2%Revenue growth, 20255
-10.2%Return on equity5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product Health Therapies brought in 60% of the revenue Agape ATP Corp broke down this way in fiscal 2025.

  1. Product Health Therapies$912.2K560%down 0% from 2024
  2. Skin Care and Health Care Products$231.7K515%up 949% from 2024
  3. Health and Wellness Services$169.3K511%down 18% from 2024
  4. Green Energy$139.7K59%up 227% from 2024
  5. Energized Mineral Concentrate$59.0K54%up 36% from 2024
  6. Livo 5$7.9K51%down 90% from 2024
  7. Mix Soy Protein Isolate Powder With Black Sesame$2.5K50%down 67% from 2024
  8. Soy Protein Isolate Powder$1.9K50%down 80% from 2024
Products and services by year
Products and services20242025
Product Health Therapies$913.3K$912.2K
Skin Care and Health Care Products$22.1K$231.7K
Health and Wellness Services$207.5K$169.3K
Green Energy$42.8K$139.7K
Energized Mineral Concentrate$43.5K$59.0K
Livo 5$76.5K$7.9K
Mix Soy Protein Isolate Powder With Black Sesame$7.4K$2.5K
Soy Protein Isolate Powder$9.4K$1.9K

Business segments

Skin Care Health And Wellness brought in 91% of the revenue Agape ATP Corp broke down this way in fiscal 2025.

  1. Skin Care Health And Wellness$1.4M591%up 8% from 2024
  2. Green Energy$139.7K59%up 227% from 2024
Business segments by year
Business segments20242025
Skin Care Health And Wellness$1.3M$1.4M
Green Energy$42.8K$139.7K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue45¢$686.0K
  • Other costs55¢$836.0K
  • Income tax0¢$2.3K

Out of $1.5M in revenue.5 The company lost money this year.

Financial statements

Revenue6789105$1.5M in 2025+18% since 2019
0$1.0M$2.0M$3.0M$4.0M2019: $1.3M$1.3M20192020: $3.4M$3.4M2020+166%2021: $1.0M$1.0M2021−70%2022: $1.9M$1.9M2022+83%2023: $1.4M$1.4M2023−23%2024: $1.3M$1.3M2024−8%2025: $1.5M$1.5M2025+15%
Gross profit6789105$838.3K in 2025+839% since 2019
0$1.0M$2.0M$3.0M2019: $89.3K$89.3K20192020: $2.7M$2.7M2020+2897%2021: $719.6K$719.6K2021−73%2022: $1.2M$1.2M2022+65%2023: $936.6K$936.6K2023−21%2024: $759.1K$759.1K2024−19%2025: $838.3K$838.3K2025+10%
Operating income6789105-$3.3M in 2025+935% since 2019
-$4.0M-$3.0M-$2.0M-$1.0M02019: -$314.6K-$314.6K20192020: -$158.1K-$158.1K2020−50%2021: -$1.9M-$1.9M2021+1075%2022: -$1.5M-$1.5M2022−18%2023: -$2.1M-$2.1M2023+40%2024: -$2.6M-$2.6M2024+20%2025: -$3.3M-$3.3M2025+27%
Net income6789105-$2.3M in 2025+218% since 2019
-$3.0M-$2.0M-$1.0M0$1.0M2019: -$716.1K-$716.1K20192020: $354.8K$354.8K20202021: -$2.5M-$2.5M20212022: -$1.7M-$1.7M2022−33%2023: -$2.1M-$2.1M2023+25%2024: -$2.5M-$2.5M2024+18%2025: -$2.3M-$2.3M2025−8%

Every line of the income statement as filed: the last 2 fiscal years, latest first.5

Period ending2025-12-312024-12-31
REVENUE$1.5M$1.3M
COST OF REVENUE-$686.0K-$563.6K
GROSS PROFIT$838.3K$759.1K
SELLING-$242.1K-$162.7K
COMMISSION-$73.7K-$34.9K
GENERAL AND ADMINISTRATIVE-$3.8M-$3.1M
TOTAL OPERATING EXPENSES-$4.1M-$3.3M
LOSS FROM OPERATIONS-$3.3M-$2.6M
Other income, net$113.8K$29.2K
Interest income$3.4K$67.9K
Unrealized holding gain (loss) on marketable securities$9.0K-$5.0K
Gain on disposal of property and equipment$112
Exchange gain, net$826.1K
Loss on disposal of non-marketable securities-$1.0K
TOTAL OTHER INCOME, NET$951.3K$92.2K
LOSS BEFORE INCOME TAXES-$2.3M-$2.5M
INCOME TAX EXPENSE-$2.3K-$4.9K
NET LOSS-$2.3M-$2.5M
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS$27.8K$15.6K
NET LOSS ATTRIBUTABLE TO AGAPE ATP CORPORATION-$2.3M-$2.5M
Foreign currency translation adjustment-$42.5K-$2.4K
TOTAL COMPREHENSIVE LOSS-$2.4M-$2.5M
Less: Comprehensive loss attributable to non-controlling interests$29.7K$15.6K
COMPREHENSIVE LOSS ATTRIBUTABLE TO AGAPE ATP CORPORATION-$2.3M-$2.5M
Basic-$2.85-$31.74
Diluted-$2.85-$31.74
Basic801.1K shares77.8K shares
Diluted801.1K shares77.8K shares

Compare Agape ATP Corp with another company

Corporate structure

Agape ATP Corp sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Agape ATP Corp

  • Agape ATP Corp Kuala Lumpur, Malaysia

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Agape ATP Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Computer equipment and software$60.2K5 Dec 31, 2025$54.6K5 Dec 31, 2024+10.3%
Property and equipment, before depreciation$461.7K5 Dec 31, 2025$417.6K5 Dec 31, 2024+10.6%
Accumulated depreciation$447.2K5 Dec 31, 2025$386.1K5 Dec 31, 2024+15.8%
Property and equipment, net$14.6K5 Dec 31, 2025$31.5K5 Dec 31, 2024−53.7%
Operating-lease assets (leased space)$102.1K5 Dec 31, 2025$224.6K5 Dec 31, 2024−54.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$140.1K5 Dec 31, 2025$2.0M5 Dec 31, 2024−93.1%
Marketable securities, non-current$22.7K5 Dec 31, 2025$13.7K5 Dec 31, 2024+65.1%
Deposits held (banks)$136.2K5 Dec 31, 2025$2.0M5 Dec 31, 2024−93.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$9.5K5 Dec 31, 2025$13.1K5 Dec 31, 2024−27.6%
Accumulated amortization$50.8K5 Dec 31, 2025$41.5K5 Dec 31, 2024+22.3%
Finite-lived intangibles, net$9.5K5 Dec 31, 2025$13.1K5 Dec 31, 2024−27.6%

Inventory

ItemLatestA year beforeChange
Inventory, total$27.4K5 Dec 31, 2025$46.3K5 Dec 31, 2024−40.9%
Raw materials$1.1K5 Dec 31, 2025$9925 Dec 31, 2024+10.3%
Finished goods$26.3K5 Dec 31, 2025$45.4K5 Dec 31, 2024−42.0%

Properties, in its own words

We currently lease 7 properties ranging from approximately 2,500 to 11,900 square feet in Kuala Lumpur and Ipoh which primarily carry out the functions of a staff accommodation, warehouse, office, service centers and sales branches in different regions of Malaysia.

Item 2 of the 10-K filed Apr 13, 2026.4

Timeline

  1. Mar 12, 20268-K Listing notice or transfer13
  2. Mar 10, 20268-K Entered a material agreement14
  3. Feb 6, 20268-K Change to shareholders' rights; Bylaws or fiscal year changed; Regulation FD disclosure15
  4. Feb 5, 20268-K Listing notice or transfer; Regulation FD disclosure16
  5. Feb 2, 20268-K Shareholder vote17
  6. Jan 29, 20268-K Listing notice or transfer18
  7. Dec 12, 20258-K Entered a material agreement19
  8. Nov 28, 20258-K Executive or director change20
  9. Jul 8, 20258-K Entered a material agreement21
  10. Apr 3, 20258-K Entered a material agreement22
  11. Mar 25, 20258-K Entered a material agreement; Unregistered sale of shares; Regulation FD disclosure23
  12. Mar 5, 20258-K Entered a material agreement; Unregistered sale of shares24
  13. May 31, 2016Founded Agape ATP Corp is founded2

Calendar

Coming up

  1. Nov 12, 2026Reports results for the quarter ending Sep/202625

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

126 filings to the SEC since October 2021: 7 annual reports, 17 quarterly reports, 45 major events, 9 large holders, 48 other. The latest 20:

  1. Aug 14, 202610-Q EDGAR
  2. Jul 20, 2026S-1/A EDGAR
  3. Jul 15, 2026SCHEDULE 13G EDGAR
  4. Jun 8, 2026S-1 EDGAR
  5. May 15, 202610-Q EDGAR
  6. Apr 13, 202610-K EDGAR
  7. Mar 31, 2026NT 10-K EDGAR
  8. Mar 12, 20268-K EDGAR
  9. Mar 10, 20268-K EDGAR
  10. Feb 6, 2026S-3 EDGAR
  11. Feb 6, 20268-K EDGAR
  12. Feb 5, 20268-K EDGAR
  13. Feb 2, 20268-K EDGAR
  14. Jan 29, 20268-K EDGAR
  15. Jan 28, 2026DEFR14A EDGAR
  16. Jan 9, 2026DEF 14A EDGAR
  17. Dec 23, 2025PRER14A EDGAR
  18. Dec 12, 20258-K EDGAR
  19. Dec 10, 2025PRE 14A EDGAR
  20. Nov 28, 20258-K EDGAR

The 126 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2024How Kok Choong61$403.0K35
2024Wilfredo Fernando Cortizo,68$36.0K$96.0K35
2024Ramesh Ruben Louis71$21.6K35
2024Ni Luh Dharma Kerti Natih61$5.4K35
2024Kadende Kaiser Rose Marie$2.7K35
2024Chee Chin Aik$035
2023How Kok Choong61$258.0K35
2023Wilfredo Fernando Cortizo,68$4.0K$10.7K35
2023Ramesh Ruben Louis71$4.7K35
2023Kadende Kaiser Rose Marie$035
2023Ni Luh Dharma Kerti Natih61$035

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Jane Street Group, LLC45,934$136.0K0.0%+22,274
Hrt Financial LP58,846$1740.0%New
UBS Group AG8$240.0%−2,582

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How Agape ATP Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAgape ATP Corp1
  • CIK0001713210
  • Employer ID (EIN)36-48388864
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company4
  • Incorporated inNevada4
  • Fiscal year endsDecember 311
  • Industry code (SIC)8000 Services-Health Services1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address1705-1708 Level 17, Tower 2, Faber Tower, Jalan Desa Bahagia, Taman Desa, Kuala Lumpur, N8 581001
  • Phone(603) 273257161
  • Shares outstanding1,000,626 as of Aug 10, 202612
  • Public float$5.4M as of Dec 31, 20254
  • AuditorAssentsure PAC, Singapore PCAOB ID 67834
  • On EDGAR sinceAug 24, 20171
  • Filings168 in all: 8-K (51), 10-Q (27), CORRESP (13), S-1/A (13), 10-K (9), SCHEDULE 13G (9), UPLOAD (9), 8-K/A (6)1
    All 26 form types

    S-1 (4), 10-K/A (3), 10-Q/A (3), DEF 14A (3), EFFECT (3), 424B3 (2), PRE 14A (2), 424B4 (1), 8-A12B (1), 8-A12B/A (1), CERT (1), DEFA14A (1), DEFR14A (1), DRS (1), NT 10-K (1), NT 10-Q (1), PRER14A (1), S-3 (1)

  • Latest filingsAnnual report (10-K) Apr 13, 2026
    Quarterly report (10-Q) Aug 14, 2026
    Proxy statement (DEF 14A) Jan 9, 2026
    Latest 8-K (8-K) Mar 12, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.0001 par valueATPCNasdaq

From the cover page of the 10-K filed Apr 13, 2026 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks Agape ATP Corp names in Item 1A of its 10-K filed Apr 13, 2026: 36 risks under these headings, as written.4

  • We are exposed to concentration risk of heavy reliance on our two largest suppliers for the supply of our products, and any shortage of, or delay in, the supply may significantly impact on our business and results of operation.
  • We could be adversely affected by a change in consumer preferences, perception and spending habits and failure to develop or enrich our product offering or gain market acceptance of our new products could have a negative effect on our business.
  • If we fail to maintain quality products and value, our sales are likely to be negatively affected.
  • If we are unable to create brand influence, we may not be able to maintain current or attract new users and customers for our products.
  • We may be unable to protect our intellectual property rights.
  • We may incur losses resulting from product liability claims or product recalls or adverse publicity relating to our products.
  • We operate in a heavily regulated industry.
  • We had previously relied on our variable interest entity, Agape S.E.A. Sdn Bhd, in Malaysia for our business operations, which may not be as effective in providing operational control or enabling us to derive economic benefits as through ownership of controlling equity interests. While we no longer rely on Agape S.E.A. Sdn Bhd for our operations, we may do so in the future.
  • Our internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated to the public.
  • Legal disputes or proceedings could expose us to liability, divert our management’s attention and negatively impact our reputation.
  • Our failure to comply with anti-corruption laws and regulations, or effectively manage our employees, customers and business partners, could severely damage our reputation, and materially and adversely affect our business, financial condition, results of operations and prospects.
  • If we are unable to successfully develop and timely introduce new products or services or enhance existing products or services, our business, financial condition and results of operations may be materially and adversely affected.
The other 24 risks
  • We have a limited operating history in the Malaysia health and wellness industry, which makes it difficult to evaluate our future prospects.
  • Our historical growth rates may not be indicative of our future growth. If we are unable to manage the growth and increased complexity of our business, fail to control our costs and expenses, or fail to execute our strategies effectively, our business and business prospects may be materially and adversely affected.
  • Our lack of insurance could expose us to significant costs and business disruption.
  • A decline in general economic condition could lead to reduced consumer demand and could negatively impact our business operation and financial condition, which in turn could have a material adverse effect on our business, financial condition and results of operations.
  • We may be adversely affected by the performance of third-party contractors.
  • We may need additional capital, and financing may not be available on terms acceptable to us, or at all.
  • Adverse developments in our existing areas of operation could adversely impact our results of business, results of operations and financial condition.
  • An overall decline in the health of the economy and other factors impacting consumer spending, such as natural disasters, outbreak of viruses, illnesses, infectious diseases, contagions and the occurrence of unforeseen epidemics may affect consumer purchases, reduce demand for our products and materially harm our business, results of operations and financial condition.
  • Fluctuations in foreign currency exchange rates could have a material adverse effect on our financial results.
  • Our business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may result in a severe impediment to our business.
  • If we are not able to achieve our overall long-term growth objectives, the value of an investment in our Company could be negatively affected.
  • Risks Related to our Industry
  • Our business and reputation may be affected by product liability claims, litigation, customer complaints, product tampering, food safety issues, food-borne illnesses, health threats, quality control concerns or adverse publicity relating to our products. Product liability insurance of our supplier may not cover our liability sufficiently or at all.
  • We operate in a highly competitive market. If we do not compete effectively, our prospects, operating results, and financial condition could be materially and adversely affected.
  • Risks Related to Doing Business in Malaysia
  • Developments in the social, political, regulatory and economic environment in Malaysia may have a material adverse impact on us.
  • We are subject to foreign exchange control policies in Malaysia.
  • Economic, market and political developments in the countries where we operate could have a material and adverse effect on our business.
  • Risks Related to our Common Stock
  • Volatility in our shares price may subject us to securities litigation.
  • We may never be able to pay dividends and are unlikely to do so.
  • Shareholders may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of securities.
  • If we fail to meet applicable listing requirements, Nasdaq may delist our ordinary shares from trading, in which case the liquidity and market price of our ordinary shares could decline.
  • We are a “smaller reporting company,” and we cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies will make our common stock less attractive to investors.
  • We expect to incur significant additional costs as a result of being a public company, which may materially and adversely affect our business, financial condition and results of operations.
  • Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be the sole source of gain.
  • Securities analysts may not publish favorable research or reports about our business or may publish no information at all, which could cause our stock price or trading volume to decline.

Legal proceedings

We know of no materials, active or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any beneficial shareholder are an adverse party or has a material interest averse to us.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35